Discussions that mention zoledronic

Osteoporosis board


"Reclast" (zoledronic acid) was recently approved by the FDA for Paget's disease, and there are currently promising Phase III studies underway for use as an osteoporosis drug. I don't know whether "off label" use for osteoporosis is permitted now.

It is administered by spinal infusion, once per year. It is still a bisphosphonate, but the adverse effects were no more frequent than were experienced by placebo.